Call us Toll-Free
800-476-6070

Weitz & Luxenberg Facebook Weitz & Luxenberg Google Weitz & Luxenberg Twitter Weitz & Luxenberg LinkedIn
English En Français

FREE LEGAL REVIEW

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
Were you diagnosed with lung cancer? Yes
Were you diagnosed with Mesothelioma? yes
What is your date of diagnosis?
Additional Comments
Best time to call?

Clinical Trials for Mesothelioma Patients: Cisplatin, Imatinib Mesylate, and Pemetrexed

Read about a current clinical trial being conducted to study the effects of Cisplatin, Imatinib Mesylate, and Pemetrexed or patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, this study is only being conducted in Lille, France.

Cisplatin, Imatinib Mesylate, and Pemetrexed in Malignant Mesothelioma Patients

Primary Objective:

1. To determine the maximum tolerated dose of the combination of cisplatin, imatinib mesylate, and pemetrexed in metastatic malignant mesothelioma.

Secondary Objectives:

1. To explore the biologic effects of cisplatin, imatinib mesylate, and pemetrexed on tumor tissue by:

1. histologic analysis of biopsy tissue

2. by non-invasive assessments of tumor vascularity performed before, during and after treatment

3. electron microscopy analysis of endothelial cell architecture after patient treatment with imatinib mesylate

2. To explore the effects of cisplatin, imatinib mesylate, and pemetrexed on surrogate markers in serum.

3. To assess the rate of response to therapy.

4. To determine the doses of the combination regimen of cisplatin, imatinib mesylate, and pemetrexed that enables de-phosphorylation of PDGF-R on malignant mesothelioma tumor cells.

5. To determine the pharmacokinetic interaction between agents in this combination regimen.

Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos
Real Stories


IN THIS SECTION
Imatinib Mesylate trial for mesothelioma patients
Outcomes of Imatinib against mesothelioma cancer
Recruitment data to test Imatinib on mesothelioma
Inclusion standard in Imatinib mesothelioma trial
Exclusion standard in Imatinib mesothelioma trial
Contact info for Imatinib mesothelioma study


RETURN BACK TO
Mesothelioma
Mesothelioma Treatments
Treatment
Clinical trials for mesothelioma

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

Mesothelioma Lawyer

Asbestos Lawyer

Mesothelioma Attorney

Asbestos Attorney

Mesothelioma Treatment

see also:

Outcomes of Imatinib against mesothelioma cancer Projected outcomes of program to treat mesothelioma with Imatinib
Possible outcomes of Imatinib program on mesothelioma patients

Exclusion standard in Imatinib mesothelioma trial Exclusion criteria to treat mesothelioma patients with Imatinib
Patient exclusion criteria for Imatinib mesothelioma clinical trial

Contact info of mesothelioma clinical trial of B12 Contact information for Vitamin B12 study on mesothelioma patients
Obtain contact info for Vitamin B12 mesothelioma clinical trial